Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...

An informational overview of Ivím Health's compounded semaglutide and tirzepatide telehealth program, including GLP-1 ID cost ...

Weight-loss medications continue to grow in popularity as an anti-obesity tool — but are some more effective than others? The question was explored in a new study published this month in The New ...

People turning to injectable GLP-1 treatments—a class of drugs that mimics that hormone to control diabetes and promote weight loss—now have another way to take the medication. On Dec. 22, the U.S.

Losing weight can feel very difficult, especially in today’s world where there are so many food choices everywhere. Many ...

Omada Health has released new data indicating that its GLP-1 companion program significantly enhances medication persistence for GLP-1 treatments, which are linked to increased weight loss. The ...

Millions of patients taking GLP-1 receptor agonists such as semaglutide have achieved dramatic weight loss, but a growing ...